newsfilter
← Latest News
GlobeNewswire·

ABVC BioPharma Announces Pricing of $1.75 Million Registered Direct Offering

FREMONT, CA, July 27, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire -- ABVC BioPharma, Inc. (NASDAQ:ABVC) ("Company"), a clinical-stage biopharmaceutical company developing therapeutic solutions in ophthalmology,